Annual Financial Report

LEI: 549300Q7EXQQH6KF7Z84

24 April 2026

RTW Biotech Opportunities Ltd (the "Company")

Annual Financial Report

A tagged copy of the Annual Report and Audited Consolidated Financial Statements for the year ended 31 December 2025 was submitted to the National Storage Mechanism on 24 April 2026 and is available for inspection at https://data.fca.org.uk/artefacts/NSM/DirectUpload/NI-000143602/reports/549300Q7EXQQH6KF7Z84-2025-12-31-1-en.xhtml

Enquiries:

About RTW Biotech Opportunities Ltd:

RTW Biotech Opportunities Ltd (LSE: RTW) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Biotech Opportunities Ltd invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives. RTW Biotech Opportunities Ltd is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.

Visit the website at www.rtwbio.com for more information.

***********

The information in this announcement may include forward-looking statements, which are based on the current expectations and projections about future events, and in certain cases can be identified by the use of terms such as "may", "will", "should", "expect", "anticipate", "project", "estimate", "intend", "continue", "target", "believe" (or the negatives thereon) or other variations thereon or comparable terminology. These forward-looking statements are subject to risks, uncertainties and assumptions, and therefore the events in the forward-looking statements may not occur.

***********